Hantavirus protein interactions regulate cellular functions and signaling responses

References

• Johnson KM. Hantaviruses: history and overview. Curr. Top. Microbiol. Immunol.256, 1–14 (2001).
   PubMed Web of Science ®Google Scholar
• Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infection in Europe. Lancet Infect. Dis.3(10), 653–661 (2003).
   PubMed Web of Science ®Google Scholar
• Schönrich G, Rang A, Lütteke N, Raftery MJ, Charbonnel N, Ulrich RG. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol. Rev.225(1), 163–189 (2008).
   PubMed Web of Science ®Google Scholar
• Jonsson CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res.78(1), 162–169 (2008).
   PubMed Web of Science ®Google Scholar
• Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. J. Infect. Dev. Ctries2(1), 3–23 (2008).
   PubMed Web of Science ®Google Scholar
• Heyman P, Vaheri A, Lundkvist Å, Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev. Anti Infect. Ther.7(2), 205–217 (2009).
   PubMed Web of Science ®Google Scholar
• Chen CC, Pei KJ, Yang CM et al. A possible case of hantavirus infection in a Borneo orangutan and its conservation implication. J. Med. Primatol.DOI: 10.1111/j.1600-0684.2010.00442.x (2010) (Epub ahead of print).
   Google Scholar
• Mertens M, Essbauer SS, Rang A et al. Non-human primates in outdoor enclosures: risk for infection with rodent-borne hantaviruses. Vet. Microbiol.DOI: 10.1016/j.vetmic.2010.07.018 (2010) (Epub ahead of print).
   Google Scholar
• Easterbrook JD, Klein SL. Immunological mechanism mediating hantavirus persistence in rodent reservoirs. PLoS Pathog.4(11), e1000172 (2008).
   Google Scholar
• Olsson GE, Leirs H, Henttonen H. Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis.10(6), 549–561 (2010).
   PubMed Web of Science ®Google Scholar
• Goldsmith CS, Eliott LH, Peters CJ, Zaki SR. Ultrastructural charachteristics of Sin nombre virus, causative agent of hantavirus pulmonary syndrome. Arch. Virol.140(12), 2107–2122 (1995).
   PubMed Web of Science ®Google Scholar
• Jääskeläinen KM, Kaukinen P, Minskaya ES et al. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-β promoter. J. Med. Virol.79(10), 1527–1536 (2007).
   PubMed Web of Science ®Google Scholar
• Jonsson CB, Schmaljohn CS. Replication of hantaviruses. Curr. Top. Microbiol. Immunol.256, 15–32 (2001).
   PubMed Web of Science ®Google Scholar
• Hardestam J, Klingström J, Mattsson K, Lundkvist Å. HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J. Med. Virol.76(2), 234–240 (2005).
   PubMed Web of Science ®Google Scholar
• Wells RM, Sosa Estani S, Yadon ZE et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg. Infect. Dis.3(2), 171–174 (1997).
   PubMed Web of Science ®Google Scholar
• Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology241(2), 323–330 (1998).
   PubMed Web of Science ®Google Scholar
• Martinez VP, Bellomo C, San Juan J et al. Person-to-person transmission of Andes virus. Emerg. Infect. Dis.11(12), 1848–1853 (2005).
   PubMed Web of Science ®Google Scholar
• Montgomery JM, Ksiazek TG, Khan AS. Hantavirus pulmonary syndrome: the sound of a mouse roaring. J. Infect. Dis.195(11), 1553–1555 (2007).
   PubMed Web of Science ®Google Scholar
• Ferres M, Vial P, Marco C et al. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J. Infect. Dis.195(11), 1563–1571 (2007).
   PubMed Web of Science ®Google Scholar
• Sinisalo M, Vapalahti O, Ekblom-Kullberg S et al. Headache and low platelets in a patient with acute leukemia. J. Clin. Virol.48(3), 159–161 (2010).
   PubMed Web of Science ®Google Scholar
• Petersen LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang.98(4), 495–503 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerg. Infect. Dis.16(8), 1195–1203 (2010).
   PubMed Web of Science ®Google Scholar
• Saggioro FP, Rossi MA, Duarte MI et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J. Infect. Dis.195(10), 1541–1549 (2007).
   PubMed Web of Science ®Google Scholar
• Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev.23(2), 412–441 (2010).
   PubMed Web of Science ®Google Scholar
• Linderholm M, Billström A, Settergren B, Tärnvik A. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection20(5), 263–266 (1992).
   PubMed Web of Science ®Google Scholar
• Linderholm M, Bjermer L, Juto P et al. Local host response in the lower respiratory tract in nephropathia epidemica. Scand. J. Infect. Dis.25(5), 639–646 (1993).
   PubMed Web of Science ®Google Scholar
• Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin. Nephrol.46(6), 369–378 (1996).
   PubMed Web of Science ®Google Scholar
• Linderholm M, Sandström T, Rinnstrom O, Groth S, Blomberg A, Tärnvik A. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin. Infect. Dis.25(5), 1084–1089 (1997).
   PubMed Web of Science ®Google Scholar
• Puljiz I, Kuzman I, Markotić A, Turcinov D, Matić M, Makek N. Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand. J. Infect. Dis.37(8), 594–598 (2005).
   PubMed Web of Science ®Google Scholar
• Paakkala A, Mustonen J. Radiological findings and their clinical correlations in nephropathia epidemica. Acta Radiol.48(3), 345–350 (2007).
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Kokkonen L, Ala-Houhala I et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand. J. Infect. Dis.41(1), 57–62 (2009).
   PubMed Web of Science ®Google Scholar
• Castillo C, Naranjo J, Sepúlveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest120(2), 548–554 (2001).
   PubMed Web of Science ®Google Scholar
• Rivers MN, Alexander JL, Rohde RE, Pierce JR Jr. Hantavirus pulmonary syndrome in Texas: 1993–2006. South Med. J.102(1), 36–41 (2009).
   PubMed Web of Science ®Google Scholar
• Rasche FM, Uhel B, Krüger DH et al. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg. Infect. Dis.10(8), 1420–1425 (2004).
   PubMed Web of Science ®Google Scholar
• Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand. J. Infect. Dis.32(2), 125–132 (2000).
   PubMed Web of Science ®Google Scholar
• Tersago K, Verhagen R, Vapalahti O, Heyman P, Ducoffre G, Leirs H. Hantavirus outbreak in Western Europe: reservoir host infection dynamics related to human disease patterns. Epidemiol. Infect.10, 1–10 (2010).
   Google Scholar
• Pettersson L, Boman J, Juto P, Evander M, Ahlm C. Outbreak of Puumala virus infection, Sweden. Emerg. Infect. Dis.14(5), 808–810 (2008).
   PubMed Web of Science ®Google Scholar
• Hofmann J, Meisel H, Klempa B et al. Hantavirus outbreak, Germany, 2007. Emerg. Infect. Dis.14(5), 850–852 (2008).
   PubMed Web of Science ®Google Scholar
• Clement J, Vercauteren J, Verstraeten WW et al. Relating increasing hantavirus incidences to the changing climate: the mast connection. Int. J. Health Geogr.8, 1 (2009).
   PubMed Web of Science ®Google Scholar
• Dearing MD, Dizney L. Ecology of hantavirus in a changing world. Ann. NY Acad. Sci.1195, 99–112 (2010).
   PubMed Web of Science ®Google Scholar
• Guan P, Huang D, He M, Shen T, Guo J, Zhou B. Investigating the effects of climatic variables and reservoir on the incidence of hemorrhagic fever with renal syndrome in Huludao City, China: a 17-year data analysis based on structure equation model. BMC Infect. Dis.9, 109 (2009).
   PubMedGoogle Scholar
• Hjertqvist M, Klein SL, Ahlm C, Klingström J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg. Infect. Dis.16(10), 1584–1586 (2010).
   PubMed Web of Science ®Google Scholar
• Makary P, Kanerva M, Ollgren J, Virtanen MJ, Vapalahti O, Lyytikäinen O. Disease burden of Puumala virus infections, 1995–2008. Epidemiol. Infect.138(19), 1484–1492 (2010).
   PubMed Web of Science ®Google Scholar
• Hautala N, Kauma H, Vapalahti O et al. Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients. Br. J. Ophthalmol.DOI: 10.1136/bjo.2010.185413 (2010) (Epub ahead of print).
   Google Scholar
• Alexeyev OA, Morozov VG. Neurological manifestations of hemorrhagic fever with renal syndrome caused by Puumala virus: review of 811 cases. Clin. Infect. Dis.20(2), 255–258 (1995).
   PubMed Web of Science ®Google Scholar
• Ahlm C, Lindén C, Linderholm M et al. Central nervous system and ophthalmic involvement in nephropathia epidemica (European type of haemorrhagic fever with renal syndrome). J. Infect.36(2), 149–155 (1998).
   PubMed Web of Science ®Google Scholar
• Mähönen SM, Sironen T, Vapalahti O et al. Puumala virus RNA in cerebrospinal fluid in a patient with uncomplicated nephropathia epidemica. J. Clin. Virol.40(3), 248–251 (2007).
   PubMed Web of Science ®Google Scholar
• Hautala T, Mähönen SM, Sironen T et al. Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Ann. Med.42(5), 344–351 (2010).
   PubMed Web of Science ®Google Scholar
• Cerar D, Avsic-Zupanc T, Jereb M, Strle F. Case report: severe neurological manifestation of Dobrava hantavirus infection. J. Med. Virol.79(12), 1841–1843 (2007).
   PubMed Web of Science ®Google Scholar
• Brorstad A, Oscarsson KB, Ahlm C. Early diagnosis of hantavirus infection by family doctors can reduce inappropriate antibiotic use and hospitalization. Scand. J. Prim. Health Care28(3), 179–184 (2010).
   PubMed Web of Science ®Google Scholar
• Vaheri A, Vapalahti O, Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev. Med. Virol.18(4), 277–288 (2008).
   PubMed Web of Science ®Google Scholar
• Hukic M, Nikolic J, Valjevac A, Seremet M, Tesic G, Markotic A. A serosurvey reveals Bosnia and Herzegovina as a Europe’s hotspot in hantavirus seroprevalence. Epidemiol. Infect.138(8), 1185–1193 (2010).
   PubMed Web of Science ®Google Scholar
• Mendes WS, da Silva AA, Neiva RF et al. Serologic survey of hantavirus infection, Brazilian Amazon. Emerg. Infect. Dis.16(5), 889–891 (2010).
   PubMed Web of Science ®Google Scholar
• Klempa B, Koivogui L, Sylla O et al. Serological evidence of human hantavirus infections in Guinea, West Africa. J. Infect. Dis.201(7), 1031–1034 (2010).
   PubMed Web of Science ®Google Scholar
• Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J. Clin. Microbiol.45(8), 2491–2497 (2007).
   PubMed Web of Science ®Google Scholar
• Golovljova I, Vasilenko V, Mittzenkov V et al. Characterization of hemorrhagic fever with renal syndrome caused by hantaviruses, Estonia. Emerg. Infect. Dis.13(11), 1773–1776 (2007).
   PubMed Web of Science ®Google Scholar
• Dzagurova TK, Klempa B, Tkachenko EA et al. Molecular diagnostics of hemorrhagic fever with renal syndrome during a Dobrava virus infection outbreak in the European part of Russia. J. Clin. Microbiol.47(12), 4029–4036 (2009).
   PubMed Web of Science ®Google Scholar
• Plyusnina A, Ferenczi E, Rácz GR et al. Co-circulation of three pathogenic hantaviruses: Puumala, Dobrava, and Saaremaa in Hungary. J. Med. Virol.81(12), 2045–2052 (2009).
   PubMed Web of Science ®Google Scholar
• Markotić A, Nichol ST, Kuzman I et al. Characteristics of Puumala and Dobrava infections in Croatia. J. Med. Virol.66(4), 542–551 (2002).
   PubMed Web of Science ®Google Scholar
• Ahlm C, Linderholm M, Juto P, Stegmayr B, Settergren B. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol. Infect.113(1), 129–136 (1994).
   PubMed Web of Science ®Google Scholar
• Henttonen H, Vaheri A, Vapalahti O. Hantavirus infections in Finland. Euro. Surveill.5, 9–11 (1995).
   Google Scholar
• Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am. J. Trop. Med. Hyg.80(2), 279–285 (2009).
   PubMed Web of Science ®Google Scholar
• Gracia F, Armien B, Simpson SQ et al. Convalescent pulmonary dysfunction following hantavirus pulmonary syndrome in Panama and the United States. Lung188(5), 387–391 (2010).
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Ala-Houhala I, Mustonen J et al. Renal function and blood pressure five years after Puumala virus-induced nephropathy. Kidney Int.58(4), 1711–1718 (2000).
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO et al. Tubular proteinuria and glomerular filtration 6 years after Puumala hantavirus-induced acute interstitial nephritis. Nephron Clin. Pract.112(2), c115–c120 (2009).
   PubMedGoogle Scholar
• Tulumovic D, Imamovic G, Mesic E et al.Comparison of the effects of Puumala and Dobrava viruses on early and long-term renal outcomes in patients with haemorrhagic fever with renal syndrome. Nephrology15(3), 340–343 (2010).
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Jaatinen P, Miettinen M et al. Hormonal deficiencies during and after Puumala hantavirus infection. Eur. J. Clin. Microbiol. Infect. Dis.29(6), 705–713 (2010).
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int.69(11), 2043–2048 (2006).
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO et al. The severity of acute Puumala hantavirus infection does not predict the long-term outcome of patients. Nephron Clin. Pract.116(2), c89–c94 (2010).
   PubMedGoogle Scholar
• Meyer BJ, Schmaljohn CS. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol.8(2), 61–67 (2000).
   PubMed Web of Science ®Google Scholar
• Manigold T, Martinez J, Lazcano X et al. Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. J. Med. Virol.80(11), 1947–1951 (2008).
   PubMed Web of Science ®Google Scholar
• Maes P, Clement J, Van Ranst M. Recent approaches in hantavirus vaccine development. Expert Rev. Vaccines8(1), 67–76 (2009).
   PubMed Web of Science ®Google Scholar
• Schmaljohn C. Vaccines for hantaviruses. Vaccine27(S4), D61–D64 (2009).
   PubMed Web of Science ®Google Scholar
• Park K, Kim CS, Moon KT. Protective effectiveness of hantavirus vaccine. Emerg. Infect. Dis.10(12), 2218–2220 (2004).
   PubMed Web of Science ®Google Scholar
• Huggins JW, Hsiang CM, Cosgriff TM et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis.164(6), 1119–1127 (1991).
   PubMed Web of Science ®Google Scholar
• Rusnak JM, Byrne WR, Chung KN et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res.81(1), 68–76 (2009).
   PubMed Web of Science ®Google Scholar
• Mertz GJ, Miedzinski L, Goade D et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin. Infect. Dis.39(9), 1307–1313 (2004).
   PubMed Web of Science ®Google Scholar
• Tamura M, Asada H, Kondo K, Takahashi M, Yamanishi K. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res.8(4), 171–178 (1987).
   PubMed Web of Science ®Google Scholar
• Alff PJ, Gavrilovskaya IN, Gorbunova E et al. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol.80(19), 9676–9686 (2006).
   PubMed Web of Science ®Google Scholar
• Stoltz M, Ahlm C, Lundkvist Å, Klingström J. Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-γ-induced nitric oxide production. J. Virol.81(16), 8685–8691 (2007).
   PubMed Web of Science ®Google Scholar
• Kirsi JJ, North JA, McKernan PA et al. Broad-spectrum antiviral activity of 2-β-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob. Agents Chemother.24(3), 353–361 (1983).
   PubMed Web of Science ®Google Scholar
• Huggins JW, Kim GR, Brand OM, McKee KT Jr. Ribavirin therapy for Hantaan virus infection in suckling mice. J. Infect. Dis.153(3), 489–497 (1986).
   PubMed Web of Science ®Google Scholar
• Medina RA, Mirowsky-Garcia K, Hutt J, Hjelle B. Ribavirin, human convalescent plasma and anti-β3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. J. Gen. Virol.88(2), 493–505 (2007).
   PubMed Web of Science ®Google Scholar
• Chung DH, Kumarapperuma SC, Sun Y et al. Synthesis of 1-β-D-ribofuranosyl-3-ethynyl-[1,2,4] triazole and its in vitro and in vivo efficacy against hantavirus. Antiviral Res.79(1), 19–27 (2008).
   PubMed Web of Science ®Google Scholar
• Chung DH, Strouse JJ, Sun Y, Arterburn JB, Parker WB, Jonsson CB. Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine. Antiviral Res.83(1), 80–85 (2009).
   PubMed Web of Science ®Google Scholar
• Hall PR, Hjelle B, Njus H et al. Phage display selection of cyclic peptides that inhibit Andes virus infection. J. Virol.83(17), 8965–8969 (2009).
   PubMed Web of Science ®Google Scholar
• Deng HY, Luo F, Shi LQ, Zhong Q, Liu YJ, Yang ZQ. Efficacy of arbidol on lethal Hantaan virus infections in suckling mice and in vitro. Acta Pharmacol. Sin.30(7), 1015–1024 (2009).
   PubMed Web of Science ®Google Scholar
• Klingström J, Stoltz M, Hardestam J, Ahlm C, Lundkvist Å. Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge. Antivir. Ther.13(1), 125–133 (2008).
   PubMed Web of Science ®Google Scholar
• Habjan M, Andersson I, Klingström J et al. Processing of genome 5´ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One3(4), e2032 (2008).
   PubMed Web of Science ®Google Scholar
• Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN, Mackow ER. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1–TRAF3 complex formation. J. Virol.82(18), 9115–9122 (2008).
   PubMed Web of Science ®Google Scholar
• Stoltz M, Klingström J. α/β interferon (IFN-α/β)-independent induction of IFN-λ1 (interleukin-29) in response to Hantaan virus infection. J. Virol.84(18), 9140–9148 (2010).
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF, Albariño CG, Ksiazek TG, Rollin PE. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol.81(6), 2769–2776 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor SL, Frias-Staheli N, García-Sastre A, Schmaljohn CS. Hantaan virus nucleocapsid protein binds to importin α proteins and inhibits tumor necrosis factor α-induced activation of nuclear factor kappa B. J. Virol.83(3), 1271–1279 (2009).
   PubMed Web of Science ®Google Scholar
• Ontiveros SJ, Li Q, Jonsson CB. Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein. Virology401(2), 165–178 (2010).
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl Acad. Sci. USA95(12), 7074–7079 (1998).
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J. Virol.73(5), 3951–3959 (1999).
   PubMed Web of Science ®Google Scholar
• Krautkrämer E, Zeier M. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol.82(9), 4257–4264 (2008).
   PubMed Web of Science ®Google Scholar
• Choi Y, Kwon YC, Kim SI, Park JM, Lee KH, Ahn BY. A hantavirus causing hemorrhagic fever with renal syndrome requires gC1qR/p32 for efficient cell binding and infection. Virology381(2), 178–183 (2008).
   PubMed Web of Science ®Google Scholar
• Mou DL, Wang YP, Huang CX et al. Cellular entry of Hantaan virus A9 strain: specific interactions with β3 integrins and a novel 70kDa protein. Biochem. Biophys. Res. Commun.339(2), 611–617 (2006).
   PubMed Web of Science ®Google Scholar
• Ye L, Liu Y, Yang S, Liao W, Wang C. Increased expression of Hsp70 and co-localization with nuclear protein in cells infected with the Hantaan virus. Chin. Med. J. (Engl.)114(5), 535–539 (2001).
   PubMed Web of Science ®Google Scholar
• Yu L, Ye L, Zhao R, Liu YF, Yang SJ. HSP70 induced by Hantavirus infection interacts with viral nucleocapsid protein and its overexpression suppresses virus infection in Vero E6 cells. Am. J. Transl. Res.1(4), 367–380 (2009).
   PubMed Web of Science ®Google Scholar
• Ravkov EV, Nichol ST, Peters CJ, Compans RW. Role of actin microfilaments in Black Creek Canal virus morphogenesis. J. Virol.72(4), 2865–2870 (1998).
   PubMed Web of Science ®Google Scholar
• Li XD, Mäkelä TP, Guo D et al. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J. Gen. Virol.83(4), 759–766 (2002).
   PubMed Web of Science ®Google Scholar
• Lee BH, Yoshimatsu BHK, Maeda A et al. Association of the N protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules. Virus Res.98(1), 83–91 (2003).
   PubMed Web of Science ®Google Scholar
• Mir MA, Sheema S, Haseeb A, Haque A. Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites. J. Biol. Chem.285(15), 11357–11368 (2010).
   PubMed Web of Science ®Google Scholar
• Mir MA, Duran WA, Hjelle BL, Ye C, Panganiban AT. Storage of cellular 5´mRNA caps in P bodies for viral cap-snatching. Proc. Natl Acad. Sci. USA105(49), 19294–19299 (2008).
   PubMed Web of Science ®Google Scholar
• Mir MA, Panganiban, AT. A protein that replaces the entire cellular eIF4F complex. EMBO J.27(23), 3129–3139 (2008).
   PubMed Web of Science ®Google Scholar
• Vera-Otarola J, Soto-Rifo R, Ricci EP, Ohlmann T, Darlix JL, López-Lastra M. The 3´ untranslated region of the Andes hantavirus small mRNA functionally replaces the poly(A) tail and stimulates cap-dependent translation initiation from the viral mRNA. J. Virol.DOI: 10.1128/JVI.01270-10 (2010) (Epub ahead of print).
   Google Scholar
• Haque A, Mir MA. Interaction of hantavirus nucleocapsid protein (N) with ribosomal protein S19. J. Virol.84(23), 12450–12453 (2010).
   PubMed Web of Science ®Google Scholar
• Hardestam J, Pettersson L, Ahlm C, Evander C, Lundkvist Å, Klingström J. Antiviral effect of human saliva against hantavirus. J. Med. Virol.80(12), 2122–2126 (2008).
   PubMed Web of Science ®Google Scholar
• Hardestam J, Lundkvist Å, Klingström J. Sensitivity of Andes hantavirus to antiviral effect of human saliva. Emerg. Infect. Dis.15(7), 1140–1142 (2009).
   PubMed Web of Science ®Google Scholar
• Godoy P, Marsac D, Stefas E et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J. Virol.83(10), 5046–5055 (2009).
   PubMed Web of Science ®Google Scholar
• Padula P, Figueroa R, Navarrete M et al. Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J. Virol.78(21), 11972–11979 (2004).
   PubMed Web of Science ®Google Scholar
• Pettersson L, Klingström J, Hardestam J, Lundkvist Å, Ahlm C, Evander M. Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg. Infect. Dis.14(3), 406–411 (2008).
   PubMed Web of Science ®Google Scholar
• Prescott JB, Hall PR, Bondu-Hawkins VS, Ye C, Hjelle B. Early innate immune responses to Sin Nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. J. Immunol.179(3), 1796–1802 (2007).
   PubMed Web of Science ®Google Scholar
• Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis.173(1), 38–43 (1996).
   PubMed Web of Science ®Google Scholar
• Krakauer T, Leduc JW, Krakauer H. Serum levels of tumor necrosis factor-α, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome. Viral Immunol.8(2), 75–79 (1995).
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Mustonen J, Ala-Houhala I et al. Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am. J. Kidney Dis.43(5), 809–816 (2004).
   PubMed Web of Science ®Google Scholar
• Borges AA, Campos GM, Moreli ML et al. Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect.10(10–11), 1150–1157 (2008).
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä SM, Ala-Houhala IO et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect. Dis.10, 132 (2010).
   PubMed Web of Science ®Google Scholar
• Tuuminen T, Kekäläinen E, Mäkelä S et al. Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J. Immunol.179(3), 1988–1995 (2007).
   PubMed Web of Science ®Google Scholar
• Linderholm M, Groeneveld PH, Tärnvik A. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome – relation to arterial hypotension and tumor necrosis factor. Infection24(5), 337–340 (1996).
   PubMed Web of Science ®Google Scholar
• Davis IC, Zajac AJ, Nolte KB, Botten J, Hjelle B, Matalon S. Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J. Virol.76(16), 8347–8359 (2002).
   PubMed Web of Science ®Google Scholar
• Klingström J, Åkerström S, Hardestam J et al. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur. J. Immunol.36(10), 2649–2657 (2006).
   PubMed Web of Science ®Google Scholar
• Maes P, Clement J, Gavrilovskaya I, Van Ranst M. Hantaviruses: immunology, treatment and prevention. Viral Immunol.17(4), 481–497 (2004).
   PubMed Web of Science ®Google Scholar
• Terajima M, Hayasaka D, Maeda K, Ennis FA. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol. Lett.113(2), 117–120 (2007).
   PubMed Web of Science ®Google Scholar
• Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis.182(1), 43–48 (2000).
   PubMed Web of Science ®Google Scholar
• MacNeil A, Comer JA, Ksiazek TG, Rollin PE. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J. Infect. Dis.202(2), 242–246 (2010).
   PubMed Web of Science ®Google Scholar
• Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol.172(5), 3297–3304 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu LY, Chi LJ, Wang X, Zhou H. Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome. Clin. Exp. Immunol.156(1), 88–96 (2009).
   PubMed Web of Science ®Google Scholar
• Klingström J, Hardestam J, Stoltz M et al. Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J. Virol.80(16), 8279–8282 (2006).
   PubMed Web of Science ®Google Scholar
• Young JC, Hansen GR, Graves TK et al. The incubation period of hantavirus pulmonary syndrome. Am. J. Trop. Med. Hyg.62(6), 714–717 (2000).
   PubMed Web of Science ®Google Scholar
• Kramski M, Achazi K, Klempa B, Krüger DH. Nephropathia epidemica with a 6-week incubation period after occupational exposure to Puumala hantavirus. J. Clin. Virol.44(1), 99–101 (2009).
   PubMed Web of Science ®Google Scholar
• Geimonen E, Neff S, Raymond T et al. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl Acad. Sci. USA99(21), 13837–13842 (2002).
   PubMed Web of Science ®Google Scholar
• Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell functions. Thromb. Haemost.102(6), 1030–1041 (2009).
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration. Arch. Virol.147(10), 1913–1931 (2002).
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Gorbunova EE, Mackow ER. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J. Virol.84(9), 4832–4839 (2010).
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol.82(12), 5797–5806 (2008).
   PubMed Web of Science ®Google Scholar
• Gorbunova E, Gavrilovskaya IN, Mackow ER. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol.84(14), 7405–7411 (2010).
   PubMed Web of Science ®Google Scholar
• Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. Andes virus disrupts the endothelial cell barrier by induction of VEGF and down-regulation of VE-cadherin. J. Virol.84(21), 11227–11234 (2010).
   PubMed Web of Science ®Google Scholar
• Pepini T, Gorbunova EE, Gavrilovskaya IN, Mackow JE, Mackow ER. Andes virus regulation of cellular microRNAs contributes to hantavirus induced endothelial cell permeability. J. Virol.84(22), 11929–11936 (2010).
   PubMed Web of Science ®Google Scholar
• Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology289(1), 6–14 (2001).
   PubMed Web of Science ®Google Scholar
• Matthys VS, Gorbunova EE, Gavrilovskaya IN, Mackow ER. Andes virus recognition of human and Syrian hamster β3 integrins is determined by an L33P substitution in the PSI domain. J. Virol.84(1), 352–360 (2010).
   PubMed Web of Science ®Google Scholar
• Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H. Antagonism of type I interferon responses by new world hantaviruses. J. Virol.84(22), 11790–11801 (2010).
   PubMed Web of Science ®Google Scholar
• Jordan WJ, Eskdale J, Srinivas S et al. Human interferon lambda-1 (IFN-γ1/IL-29) modulates the Th1/Th2 response. Genes Immun.8(3), 254–261 (2007).
   PubMed Web of Science ®Google Scholar
• Dai J, Megjugorac NJ, Gallagher GE, Yu RYL, Gallagher G. IFN-γ1 (IL29) inhibits GATA3 expression and suppresses Th2 responses in human naïve and memory T cells. Blood113(23), 5829–5838 (2009).
   PubMed Web of Science ®Google Scholar
• Morrow MP, Pankhong P, Laddy DJ et al. Comparative ability of IL-12 and IL-28B to regulate Treg cell populations and enhance adaptive cellular immunity. Blood113(23), 5868–5877 (2009).
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int.49(1), 217–221 (1996).
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Mustonen J, Ala-Houhala I et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism. J. Infect. Dis.186(6), 843–846 (2002).
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand. J. Immunol.47(3), 277–279 (1998).
   PubMed Web of Science ®Google Scholar
• Mustonen J, Huttunen NP, Partanen J et al. Human leukocyte antigens B8-DRB1*03 in pediatric patients with nephropathia epidemica caused by Puumala hantavirus. Pediatr. Infect. Dis. J.23(10), 959–961 (2004).
   PubMed Web of Science ®Google Scholar
• Wang ML, Lai JH, Zhu Y et al. Genetic susceptibility to haemorrhagic fever with renal syndrome caused by Hantaan virus in Chinese Han population. Int. J. Immunogenet.36(4), 227–229 (2009).
   PubMed Web of Science ®Google Scholar
• Klein SL, Calisher CH. Emergence and persistence of hantaviruses. Curr. Top. Microbiol. Immunol.315, 217–252 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez VP, Bellomo CM, Cacace ML et al. Hantavirus pulmonary syndrome in Argentina, 1995–2008. Emerg. Infect. Dis.DOI: 10.3201/eid1612.091170 (2010) (Epub ahead of print).
   Google Scholar
• Klingström J, Lindgren T, Ahlm C. Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin. Vaccine Immunol.15(5), 885–887 (2008).
   PubMed Web of Science ®Google Scholar
• Wahl-Jensen V, Chapman J, Asher L et al. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J. Virol.81(14), 7449–7462 (2007).
   PubMed Web of Science ®Google Scholar
• Klingström J, Plyusnin A, Vaheri A, Lundkvist Å. Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J. Virol.76(1), 444–449 (2002).
   PubMed Web of Science ®Google Scholar
• Sironen T, Klingström J, Vaheri A, Andersson LC, Lundkvist Å, Plyusnin A. Pathology of Puumala hantavirus infection in macaques. PLoS One3(8), e3035 (2008).
   PubMed Web of Science ®Google Scholar
• Klingström J, Hardestam J, Lundkvist Å. Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice. Microbes Infect.8(3), 728–737 (2006).
   PubMed Web of Science ®Google Scholar
• Easterbrook JD, Zink MC, Klein SL. Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc. Natl Acad. Sci. USA104(39), 15502–15507 (2007).
   PubMed Web of Science ®Google Scholar
• Schountz T, Prescott J, Cogswell AC et al. Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc. Natl Acad. Sci. USA104(39), 15496–15501 (2007).
   PubMed Web of Science ®Google Scholar
• Kukkonen SKJ, Vaheri A, Plyusnin A. Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein. J. Gen. Virol.85(5), 1181–1189 (2004).
   PubMed Web of Science ®Google Scholar
• Kukkonen SKJ, Vaheri A, Plyusnin A. L protein, the RNA-dependent RNA-polymerase of hantaviruses. Arch. Virol.150(3), 533–556 (2005).
   PubMed Web of Science ®Google Scholar
• Chung DH, Sun Y, Parker WB, Arterburn JB, Bartolucci A, Jonsson CB. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. J. Virol.81(21), 11722–11729 (2007).
   PubMed Web of Science ®Google Scholar
• Löber C, Anheier B, Lindow S, Klenk HD, Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology289(2), 224–229 (2001).
   PubMed Web of Science ®Google Scholar
• Hepojoki J, Strandin T, Vaheri A, Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. J. Virol.84(1), 227–242 (2010).
   PubMed Web of Science ®Google Scholar
• Hepojoki J, Strandin T, Wang H, Vapalahti O, Vaheri A, Lankinen H. Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. J. Gen. Virol.91(9), 2341–2350 (2010).
   PubMed Web of Science ®Google Scholar
• Larson RS, Brown DC, Ye C, Hjelle B. Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the β3-integrin receptor. J. Virol.79(12), 7319–7326 (2005).
   PubMed Web of Science ®Google Scholar
• Estrada DF, Boudreaux DM, Zhong D, St Jeor SC, De Guzman RN. The Hantavirus glycoprotein G1 tail contains dual CCHC-type classical zinc fingers. J. Biol. Chem.284(13), 8654–8660 (2009).
   PubMedGoogle Scholar
• Geimonen E, LaMonica R, Springer K, Farooqui Y, Gavrilovskaya IN, Mackow ER. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol.77(2), 1638–1643 (2003).
   PubMed Web of Science ®Google Scholar
• Geimonen E, Fernandez I, Gavrilovskaya IN, Mackow ER. Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J. Virol.77(20), 10760–10868 (2003).
   PubMed Web of Science ®Google Scholar
• Kaukinen P, Vaheri A, Plyusnin A. Hantavirus nucleocapsid protein: a multifunctional molecule with both housekeeping and ambassadorial duties. Arch. Virol.150(9), 1693–1713 (2005).
   PubMed Web of Science ®Google Scholar
• Plyusnin A. Genetics of hantaviruses: implications to taxonomy. Arch. Virol.147(4), 665–682 (2002).
   PubMed Web of Science ®Google Scholar
• Virtanen JO, Jääskeläinen KM, Djupsjöbacka J, Vaheri A, Plyusnin A. Tula hantavirus NSs protein accumulates in the perinuclear area in infected and transfected cells. Arch. Virol.155(1), 117–121 (2010).
   PubMed Web of Science ®Google Scholar
• Jääskeläinen KM, Plyusnina A, Lundkvist A, Vaheri A, Plyusnin A. Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF. Virol. J.5, 3 (2008).
   PubMedGoogle Scholar